医脉通首页
软件中心
频道导航
资讯
病例
专题
圈子
指南
期刊文献
诊疗知识库
e信使
e讲堂
e调研
会议
医生工具
互助区
登录
注册
搜索词条
新版本
知识库首页
分类索引
我的知识库
前列腺癌 -
推荐文献
概览
简介
名称与编码
精要
历史
致谢
缩略语表
基础
定义
流行病学
病因
病理解剖
病理生理
分类分型
预防
预防
筛检
诊断
问诊与查体
疾病演变
辅助检查
并发症
诊断标准
诊断程序
鉴别诊断
治疗
治疗目标
治疗细则
管理与监测
治疗程序
治疗进展
护理与照顾
随访
随访要点
预后
患者教育
临床资料
诊疗指南
临床路径
病例
临床问题
文献资料
参考文献
网络资源
推荐文献
课件
图片
聚合阅读>>
推荐文献
[Meta分析]Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research.
The 26th Annual Prostate Cancer Foundation Scientific Retreat Report.
A Patient-Centered Approach to Research Prioritization in Prostate Cancer.
Prostate Cancer Treatment and Work: A Scoping Review.
[临床试验]Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort.
Insulinemic and Inflammatory Dietary Patterns and Risk of Prostate Cancer.
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Regional Adoption of Commercial Gene Expression Testing for Prostate Cancer.
[比较研究]Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
[评论]Reply to Salma Kaochar, Nicholas Mitsiades' Letter to the Editor re: Umang Swami, Pedro Isaacsson Velho, Roberto Nussenzveig, et al. Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer. Eur Urol 2020, 78:652-6. Can Mutant SPOP Become an Actionable Biomarker for Precision Oncology Management of Prostate Cancer?: SPOP as a Potential Treatment Selection Marker in Prostate Cancer.
[综述]Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021.
[综述]Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer.
Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.
[指南]EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Specific Detection of Prostate Cancer Cells in Urine by RNA In Situ Hybridization.
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.
Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis.
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.
统计信息
录入日期：2011-07-22
最近更新：2015-03-16
浏览次数：32685
编辑次数：70
我要参编
参编团队
热心编写者
wuchangming8306
harrytt
幽幽岁月
更多>>
知识库免责声明
本诊疗知识库所提供的有关疾病检查、诊断、治疗以及预防等所有信息，仅供医生参考和学习，不面向患者，不能代替任何医生的处方和医嘱。
如果你对诊疗知识库有任何建议和意见，请联系
010-64405225
。
关于我们
|
联系我们
|
隐私政策
|
版权声明
|
免责声明
|
公司产品
|
网站帮助
北京医脉互通公司 版权所有
（京）-非经营性-2018-0300
京公网安备
11010502036930
京ICP备
13043379
号-5
京ICP证
130463
号
©
2005-2026 medlive.cn, all rights reserved
